Now I'm not uneasy about the effectiveness of leronlimab to help in covid, my discomfort lies with the regulatory entities and their reaction to the data. However if the "discussions" include Drs. Jay, Seethamraju, and Agresti along with the CYDY team...kinda like the Philippines meeting. That would give me a bit more confidence. Doctors with first hand experience telling the FDA this thing needs to be let out into the wild because it works.

I gotta believe real doctors not on CYDYs payroll asking the FDA to give this tool the thumbs up has to count for something. They are at ground zero, how can you tell them no, it missed by a point (if the PE indeed is not met which no one knows for sure).
They gave into Dr. Seethamraju for EIND...why not EUA? They both share an E in the acronym..the ICD 10 code is ready for action. Why say no when it feels so good to say yes?